Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 166 to 180 of 676 results for diabetes

  1. Management of type 3c diabetes:- What is the most clinically effective and cost-effective insulin regimen to minimise hypo- and hyperglycaemia for type 3c diabetes secondary to pancreatitis?

    type 3c diabetes:- What is the most clinically effective and cost-effective insulin regimen to minimise hypo- and hyperglycaemia for...

  2. Multimorbidity: clinical assessment and management (NG56)

    This guideline covers optimising care for adults with multimorbidity (multiple long-term conditions) by reducing treatment burden (polypharmacy and multiple appointments) and unplanned care. It aims to improve quality of life by promoting shared decisions based on what is important to each person in terms of treatments, health priorities, lifestyle and goals. The guideline sets out which people are most likely to benefit from an approach to care that takes account of multimorbidity, how they can be identified and what the care involves.

  3. Continuous glucose monitoring in children and young people with type 2 diabetes: What is the effectiveness and cost effectiveness of continuous glucose monitoring devices in children and young people with type 2 diabetes?

    Continuous glucose monitoring in children and young people with type 2 diabetes: What is the effectiveness and cost effectiveness of...

  4. Drug-eluting stents for the treatment of coronary artery disease (TA152)

    Evidence-based recommendations on using drug-eluting stents in adults.

  5. Rehabilitation for adults with complex psychosis (NG181)

    This guideline covers mental health rehabilitation for adults with complex psychosis. It aims to ensure people can have rehabilitation when they need it and promotes a positive approach to long-term recovery. It includes recommendations on organising rehabilitation services, assessment and care planning, delivering programmes and interventions, and meeting people’s physical healthcare needs.

  6. Diabetes: annual psychological assessment (children)

    This indicator has been updated and replaced by NICE indicator 313 and NICE indicator 314.

  7. Diabetes: thyroid disease screening (children)

    This indicator has been updated and replaced by NICE indicator 312.

  8. Diabetes: annual smoking status (children)

    This indicator has been updated and replaced by NICE indicator 310 and NICE indicator 311.

  9. Diabetes: annual foot examination (children)

    This indicator has been updated and replaced by NICE indicator 308 and NICE indicator 309.

  10. Diabetes: annual eye screening (children)

    This indicator has been updated and replaced by NICE indicator 306 and NICE indicator 307.

  11. Diabetes: annual urinary albumin (children)

    This indicator has been updated and replaced by NICE indicator 304 and NICE indicator 305.

  12. Diabetes: annual blood pressure (children)

    This indicator has been updated and replaced by NICE indicator 302 and NICE indicator 303.

  13. Diabetes: annual care processes (children)

    This indicator has been updated and replaced by NICE indicator 296 and NICE indicator 297.

  14. Naltrexone–bupropion for managing overweight and obesity (TA494)

    Evidence-based recommendations on naltrexone–bupropion (Mysimba) for managing overweight and obesity in adults.

  15. Social care for older people with multiple long-term conditions (QS132)

    This quality standard covers the planning and delivery of social care and support for older people (aged 65 and over) with multiple long-term conditions. It includes people living in their own homes, in specialist settings or in care homes, both those who receive support with funding for their social care and those who do not. It describes high-quality care in priority areas for improvement.